Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-26

Clinical Trial Update: Fecal Microbiota Transplantation Via Oral Capsule for Treating Refractory Constipation in Parkinson's Disease [NA]

View source ↗

Summary

A completed clinical trial evaluated fecal microbiota transplantation delivered via an oral capsule to treat refractory constipation in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation via oral capsule (fecal microbiota transplantation)

Snippet

Sponsor: Kyung Hee University Hospital | Conditions: Parkinson Disease, Constipation | NA | Status: COMPLETED